Researchers have debunked key beliefs about addiction, like that a person must hit "rock bottom" before having treatment or ...
The vast majority of people who have a substance use disorder (SUD) never seek treatment. At most, 10% of adults with a drug ...
Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...
Across 21 countries, proportion of 12-month person-disorders receiving effective treatment was 6.9 percent. (HealthDay News) — A small number of individuals with mental and substance use disorders ...
Lawyers face immense pressure in their careers. Long hours, high demands, and constant stress can take a toll. For some, this ...
Clinical neuroscientist Joe Schacht offered an overview of the research on weight-loss drugs for alcoholism, other potential ...
Perspective from Adam Bisaga, MD Although the prevalence of substance use disorder increased during the COVID-19 pandemic, the receipt of treatment declined before rebounding, according to a ...
A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...
"Love Is Blind" contestant Devin Buckley admits to being addicted to ibuprofen. But is that possible? Here, MDs explain ...
Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
Adial Pharmaceuticals Secures Patent for Genetically Targeted Treatment Methods in Addiction Therapy
particularly given the competition in the addiction treatment sector. AD04 is an investigational drug aimed at treating Alcohol Use Disorder and shows potential for other addictions like opioid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results